Francesco Lo Monaco: The Supplement You Take for Your Heart Could Be the One Increasing Your Risk of a Heart Attack
Francesco Lo Monaco, Cardiologist and Founder of The National Heart Clinic, posted on LinkedIn:
“The supplement you take for your heart could be the one increasing your risk of a heart attack.
People trying to do the right thing for their health… taking supplements they believe are protective…
and unintentionally increasing their cardiovascular risk instead.
Here’s what many don’t know:
- Calcium on its own.
High-dose calcium without vitamin D can do the opposite of what you expect, instead of strengthening your bones, it may harden your arteries.
Studies show up to a 30% higher risk of heart attack with calcium alone.
When vitamin D is added, that risk disappears. - Niacin (Vitamin B3)
Once seen as “heart-protective”, niacin in high doses can trigger inflammation inside blood vessels, doubling heart attack and stroke risk.
Ironically, it cancels out the very benefit it’s meant to give. - Fish Oil
If you already have heart disease, fish oil might help.
But if your heart is healthy, regular excessive use can increase the risk of irregular heartbeats. - Red Yeast Rice and ‘Natural’ Heart Supplements.
Many of these contain the same active compounds as prescription statins, without proper monitoring.
That means possible muscle damage, toxicity, or dangerous interactions if you’re already on medication.
My advice:
Supplements are good but they can have real effects, and sometimes, real risks.
Before starting anything, ask yourself:
→ Do I actually need this?
→ Is it based on my blood work and clinical context?
→ Am I combining it safely with other treatments?
Because prevention is powerful, but only when it’s personalised and guided by data.
If you’re investing in your health and longevity, make sure your supplements are helping, not silently harming.”
Stay updated with Hemostasis Today.
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin